Terravitals Migryx

Manufacturer
Terravitals LLC
Effective date
2022-10-07
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
legacy-cache
Hydrated at
2026-08-01 21:52:07

Label at a glance#

ProductTerravitals Migryx
Active ingredientMAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, ANTIMONY POTASSIUM TARTRATE, SILICON DIOXIDE, ZINC, SELENIUM
Label structure10 sections

Storage and handling

Other information: Store in a dry place between 15-30°C (59-86°F) and out of direct sunlight.

Label contents#

Full prescribing information#

Terravitals Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

** Active ingredients .............................................................Purpose

Antimon tart 8C HPUS...............pain with dizziness, need eyes closed
Mag phos 30C HPUS...............................pain whole head with nausea
Selenium 6C HPUS.................. pain aggravated by heat, strong smells
Silicea 30C HPUS....... head pressure ascending from neck to forehead
Zinc met 8C HPUS...........pain on temples, forehead, and back of head

'HPUS' indicates that this ingredient is officially included in the Homeopathic
Pharmacopoeia of the United States.

Internal small package:

Internal small packageInternal small package

Terravitals Purpose

OTC - PURPOSE SECTION

** Active ingredients ........................................................Purpose
Antimon tart 8C HPUS...............pain with dizziness, need eyes closed
Mag phos 30C HPUS..................................pain whole head with nausea
Selenium 6C HPUS.................. pain aggravated by heat, strong smells
Silicea 30C HPUS....... head pressure ascending from neck to forehead
Zinc met 8C HPUS...........pain on temples, forehead, and back of head
'HPUS' indicates that this ingredient is officially included in the Homeopathic
Pharmacopoeia of the United States.

* Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Terravitals Warnings

WARNINGS SECTION

Warnings Stop use and ask a doctor If symptoms persist more than 5 days or worsen. If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

INDICATIONS & USAGE SECTION

Directions - Adults and adolescents 12 and over: Dissolve 1-2 pellets in mouth after breakfast to prevent symptoms.
At the onset of symptoms, repeat every 1- 6 hours as needed.

Terravitals Dosage

DOSAGE & ADMINISTRATION SECTION

Oral soluble pellets

Terravitals Other

STORAGE AND HANDLING SECTION

Other information: Store in a dry place between 15-30°C (59-86°F) and out of direct sunlight.

OTC - DO NOT USE SECTION

Do not use if the seal of pellet dispenser inside is missing or broken.

Terravitals Inactive Ingredient

INACTIVE INGREDIENT SECTION

Inactive ingredient Organic Sucrose certified by DE-OKO-070. (Organic logo)

Terravitals main panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

TERRAVITALS Migryx

Homeopathic Medicine

For migraine relief

NDC 74474-501-01

Approx 75 Oral soluble pellets

Non-drowsy

Not habit-forming

No drug interactions

No known side effects

Made in the USA by Terravitals LLC, Gaithersburg MD 20879

www.terravitals.com

Exp: MM/YYYY

Lot: CTYYADDXX

External package label:

External package labelExternal package label

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
74474-50174474-501-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
2b3960c8-0220-b2dd-e063-6394a90ab472ea78fa5c-4f2e-5008-e053-2995a90ad4ed2025-01-08WarningsExact identifier
spl set id: ea78fa5c-4f2e-5008-e053-2995a90ad4ed

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.